Tabula Rasa HealthCare

Patient Engagement May Help Prevent Drug Interactions, Related Opioid Overdoses

In The News | Jan 12, 2022

Tabula Rasa HealthCare’s Jacques Turgeon, BPharm, PhD, Chief Scientific Officer and CEO, TRHC Precision Pharmacotherapy Research and Development Institute is featured in Pharmacy Times. Turgeon discusses research related to drug interactions and how pharmacists’ engagement with patients can promote medication safety.

Share this:
Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4